BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4649480)

  • 1. [The clinical pharmacology of olitoriside].
    Tsibekmakher TD; Vinogradov AV
    Kardiologiia; 1972 Oct; 12(10):70-3. PubMed ID: 4649480
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electroca rdiographic control in clinical use of mean therapeutic doses of cardiac glycosides (strophanthin, corglycon)].
    Fan-Tkhi-Ngok-Shiong
    Ter Arkh; 1974; 46(6):83-9. PubMed ID: 4473844
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of actodigin (AY-22,241) in patients with cardiac insufficiency and chronic auricular fibrillation or flutter].
    Bojorges R; Cárdenas M; Pastelín G; Mendez R
    Arch Inst Cardiol Mex; 1974; 44(4):615-23. PubMed ID: 4847978
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of cardiac glycosides of strophanthin-like action in the pharmacotherapy of chronic circulatory insufficiency].
    Leshchinskiĭ LA; Karbasnikova GV; Zabel'ian OM; Vasil'kova AA
    Kardiologiia; 1978 Mar; 18(3):76-83. PubMed ID: 347140
    [No Abstract]   [Full Text] [Related]  

  • 5. [Unfavourable cardiovascular effects of propranolol].
    Lega P; Milazzotto F
    Clin Ter; 1968 Jun; 45(5):461-8. PubMed ID: 5737086
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of the sugar component in cardiac glycosides on their action in patients with auricular fibrillation and congestive failure.
    Gold H; Kwit NT; Shane SJ; Dayrit C
    J Clin Pharmacol J New Drugs; 1969; 9(3):148-54. PubMed ID: 5255179
    [No Abstract]   [Full Text] [Related]  

  • 7. [Glycoside treatment characteristics in circulatory insufficiency with inflammatory processes in the heart].
    Perchikova GE
    Kardiologiia; 1975 Oct; 15(10):59-61. PubMed ID: 1234915
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the clinical effect of treatment with cardiac glycosides under conditions of ambulatory observation].
    Nasonova TI
    Kardiologiia; 1977 Sep; 17(9):53-7. PubMed ID: 926602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cliical aspects of cardiocinetic therapy with a new cardioactive glucoside: acetyldigoxin].
    Malaguti P
    Minerva Cardioangiol; 1968 Mar; 16(3):225-30. PubMed ID: 5740756
    [No Abstract]   [Full Text] [Related]  

  • 10. [Quantitative studies on the therapeutic range of cardiac glycosides].
    Diederen W; Kadatz R
    Arztl Forsch; 1970 May; 24(5):149-55. PubMed ID: 5538016
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diuretic interaction with cardiac glycosides in mitral defect patients].
    Bakaev VV; Arkhipova GF; Kelin EP
    Vrach Delo; 1979 Nov; (11):25-7. PubMed ID: 524810
    [No Abstract]   [Full Text] [Related]  

  • 12. [Quantitative therapy with cardiac glycosides].
    Storz H
    Med Welt; 1966 Aug; 35():1802-8. PubMed ID: 5975346
    [No Abstract]   [Full Text] [Related]  

  • 13. [The therapy of cardiac insufficiency using Theo-Alvonal].
    Kettermann W
    Munch Med Wochenschr; 1968 Jan; 110(4):228-32. PubMed ID: 5695033
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the clinical trial of a heart and coronary drug].
    Eisel K; Kaiser H
    Ther Ggw; 1968 Feb; 107(2):231-2 passim. PubMed ID: 5718464
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cardiac glycoside treatment of rheumatic heart disease with circulatory insufficiency].
    Kats GL; Krasnokutskaia TP; Alifanova RE; Vatutin NT
    Vrach Delo; 1979 Oct; (10):66-70. PubMed ID: 516640
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studie on the problem of long-term therapy using cardiac glycosides].
    Basche-Langer M; Schmidt-Voigt J; Klepzig H
    Dtsch Med Wochenschr; 1968 Nov; 93(48):2338-41. PubMed ID: 5696573
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of nerobol on the contractile capacity of the myocardium].
    Beĭ PI
    Klin Med (Mosk); 1972 Jan; 50(1):69-74. PubMed ID: 5020033
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of the coronary syndrome and cardiac failure. Experiences with Adenylocrat and Adenylocrat-Digoxin].
    Vargha A
    Munch Med Wochenschr; 1970 Dec; 112(49):2247-51. PubMed ID: 5536817
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of K-strophanthin beta and olitoriside on the content of glycogen and macroergic phosphorus compounds in the myocardium in experimental myocarditis].
    Turakulov IaKh; Khalikov TR; Abidov AA
    Biull Eksp Biol Med; 1972 Jan; 73(1):43-5. PubMed ID: 5011191
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of vitamin B 15 on myocardial contractility and cardiotonic effect of strophanthin in ischaemic heart disease.
    Apanasenko AA
    Cor Vasa; 1973; 15(1):20-8. PubMed ID: 4703670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.